Satellos Bioscience Inc. (TSX:MSCL)
13.38
-0.47 (-3.39%)
Aug 14, 2026, 3:59 PM EST
Satellos Bioscience Employees
As of December 31, 2025, Satellos Bioscience had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees increased by 4 or 23.53% compared to the previous year.
Employees
21
Change (1Y)
4
Growth (1Y)
23.53%
Revenue / Employee
n/a
Profits / Employee
-2.46M CAD
Market Cap
278.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2024 | 17 | 1 | 6.25% | 14 | 3 |
| Dec 31, 2023 | 16 | - | - | 4 | 12 |
Related Stocks
| Company Name | Employees |
|---|---|
| Eupraxia Pharmaceuticals | 49 |
| Bright Minds Biosciences | 26 |
| BriaCell Therapeutics | 16 |
| Sernova Biotherapeutics | 8 |
| Helix BioPharma | 7 |
Satellos Bioscience News
- 1 day ago - Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress - GlobeNewsWire
- 1 day ago - Satellos Bioscience Registration statement: Q2 2026 - Filings
- 1 day ago - Satellos Bioscience Registration statement: Q2 2026 - Filings
- 1 day ago - Satellos Bioscience Earnings release: Q2 2026 - Filings
- 3 days ago - Satellos files $300M mixed securities shelf - TheFly
- 4 days ago - Satellos Bioscience Registration statement: Registration filing - Filings
- 5 weeks ago - Satellos Bioscience DMD Drug Shows Early Promise in 6-Month Study Update - MarketBeat
- 5 weeks ago - Satellos price target raised to $18 from $11 at H.C. Wainwright - TheFly